EV20, a Novel Anti-ErbB-3 Humanized Antibody, Promotes ErbB-3 Down-Regulation and Inhibits Tumor Growth In Vivo

ErbB-3 (HER-3) receptor is involved in tumor progression and resistance to therapy. Development of specific inhibitors impairing the activity of ErbB-3 is an attractive tool for cancer therapeutics. MP-RM-1, a murine monoclonal antibody targeting human ErbB-3, has shown anticancer activity in precli...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Sala, Gianluca, Rapposelli, Ilario Giovanni, Ghasemi, Reza, Piccolo, Enza, Traini, Sara, Capone, Emily, Rossi, Cosmo, Pelliccia, Angela, Di Risio, Annalisa, D'Egidio, Maurizia, Tinari, Nicola, Muraro, Raffaella, Iacobelli, Stefano
Format: Artigo
Jezik:Inglês
Izdano: Neoplasia Press Inc. 2013
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3890702/
https://ncbi.nlm.nih.gov/pubmed/24466370
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items